Next Article in Journal
Nutritional Regulation of Gene Expression: Carbohydrate-, Fat- and Amino Acid-Dependent Modulation of Transcriptional Activity
Next Article in Special Issue
The Crosstalk Between Cell Adhesion and Cancer Metabolism
Previous Article in Journal
A Temporal Order in 5′- and 3′- Processing of Eukaryotic tRNAHis
Previous Article in Special Issue
Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide
Open AccessReview

Current Status and Future Prospects of Clinically Exploiting Cancer-specific Metabolism—Why Is Tumor Metabolism Not More Extensively Translated into Clinical Targets and Biomarkers?

Department of Molecular Biology, Umeå University, SE-90187 Umeå, Sweden
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(6), 1385; https://doi.org/10.3390/ijms20061385
Received: 31 January 2019 / Revised: 14 March 2019 / Accepted: 15 March 2019 / Published: 19 March 2019
(This article belongs to the Special Issue Cancer Cell Metabolism—Pathways and Biology)
Tumor cells exhibit a specialized metabolism supporting their superior ability for rapid proliferation, migration, and apoptotic evasion. It is reasonable to assume that the specific metabolic needs of the tumor cells can offer an array of therapeutic windows as pharmacological disturbance may derail the biochemical mechanisms necessary for maintaining the tumor characteristics, while being less important for normally proliferating cells. In addition, the specialized metabolism may leave a unique metabolic signature which could be used clinically for diagnostic or prognostic purposes. Quantitative global metabolic profiling (metabolomics) has evolved over the last two decades. However, despite the technology’s present ability to measure 1000s of endogenous metabolites in various clinical or biological specimens, there are essentially no examples of metabolomics investigations being translated into actual utility in the cancer clinic. This review investigates the current efforts of using metabolomics as a tool for translation of tumor metabolism into the clinic and further seeks to outline paths for increasing the momentum of using tumor metabolism as a biomarker and drug target opportunity. View Full-Text
Keywords: translational medicine; metabolomics; metabolism; cancer; tumor; biomarker; drug discovery; metabolic homeostasis translational medicine; metabolomics; metabolism; cancer; tumor; biomarker; drug discovery; metabolic homeostasis
Show Figures

Figure 1

MDPI and ACS Style

Muthu, M.; Nordström, A. Current Status and Future Prospects of Clinically Exploiting Cancer-specific Metabolism—Why Is Tumor Metabolism Not More Extensively Translated into Clinical Targets and Biomarkers? Int. J. Mol. Sci. 2019, 20, 1385.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop